Spontaneous splenic rupture due to rivaroxaban.

Abstract

In the prevention and treatment of thromboembolic disease, novel oral anticoagulants have emerged as alternatives to warfarin. A major challenge continues to be the reversal of their anticoagulant effect in the case of life-threatening haemorrhagic complications. We report a case of spontaneous splenic rupture treated by splenic artery embolisation in a 77-year-old woman who was anticoagulated with rivaroxaban.

• Authors: Vinayak Nagaraja, Greg Cranney, Virag Kushwaha
• Journal: BMJ case reports (BMJ Case Rep) Vol. 2018 (Mar 05 2018) ISSN: 1757-790X [Electronic] England
• PMID: 29507024 (Publication Type: Case Reports, Journal Article)
• Copyright: © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Chemical References

• Factor Xa Inhibitors
• Rivaroxaban

Topics

• Aged
• Atrial Fibrillation (drug therapy)
• Factor Xa Inhibitors (adverse effects)
• Female
• Hemorrhage (etiology)
• Humans
• Rivaroxaban (adverse effects)
• Rupture, Spontaneous (chemically induced)
• Splenic Artery (surgery)
• Splenic Rupture (chemically induced, diagnostic imaging, surgery)